Larry Clark's legacy: Randomized controlled, selenium-based prostate cancer chemoprevention trials

Nutrition and Cancer

Volumn 40, Issue 1, 2001, Pages 74-77

  Marshall, J R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENITE; SELENIUM DERIVATIVE; SELENOCYSTEINE; SELENODIGLUTATHIONE; SELENOETHIONINE; SELENOMETHIONINE; SELENOMETHYLSELENOCYSTEINE; UNCLASSIFIED DRUG;

CANCER GRADING; CANCER REGISTRY; CANCER RISK; CLINICAL TRIAL; FOLLOW UP; HUMAN; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE EPITHELIUM; REVIEW; TREATMENT OUTCOME;

EID: 0035678418     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC401_13     Document Type: Review

References (13)

1. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial
2. Selenium and cancer prevention. Promising results indicate further trials required
3. Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity
4. Lessons from basic research in selenium and cancer prevention
5. Naturally occurring selenium compounds in cancer chemoprevention trials: A workshop summary
6. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
7. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer
8. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: Relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate
9. Chromatin texture signatures in nuclei from prostate lesions
10. Statistical histometry of the basal cell/secretory cell bilayer in prostatic intraepithelial neoplasia
11. Cellular thioredoxin reductase activity is regulated by selenium
12. Results of conservative management of clinically localized prostate cancer
13. A decision analysis of alternative treatment strategies for clinically localized prostate cancer